Jhon Carlos Castaño-Osorio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Jhon Carlos Castaño-Osorio has a total of 120 co-authors. Here are the top co-authors by number of shared publications:
- Leonardo Padilla Sanabria
Molecular Immunology Group (GYMOL), Universidad del Quindío, Avenida Bolívar 12N-001, Armenia 630004, Colombia
12 shared publications - Germán Alberto Téllez Ramírez
Center of Biomedical Research, Group of Molecular Immunology, Universidad del Quindío, Armenia 630001, Quindío, Colombia
8 shared publications - Delia Piedad Recalde-Reyes
Molecular Biology and Virology Laboratory, Faculty of Medicine and Health Sciences, Corporación Universitaria Empresarial Alexander von Humboldt, Armenia 630003, Quindío, Colombia
6 shared publications - María Mercedes González
GEPAMOL/GYMOL Research Group, Faculty of Health Sciences, Universidad del Quindío, Armenia 630004, Colombia
6 shared publications - Carlos Andrés Rodríguez Salazar
Molecular Biology and Virology Laboratory, Faculty of Medicine and Health Sciences, Corporación Universitaria Empresarial Alexander von Humboldt, Armenia 630003, Quindío, Colombia
5 shared publications - Lily Johanna Toro
Centro de Investigaciones Biomédicas - Universidad del Quindío
5 shared publications
Latest Publications
- Open Access
- 13 October 2026
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 11 (10) , 290
Hepatitis E Virus Genotype 3 in Quindío, Colombia: One Health Surveillance and First Genomic Characterization Reveal Cryptic Regional Divergence
Hepatitis E virus genotype 3 (HEV-3) is a zoonotic pathogen whose burden in Latin America remains underestimated. We conducted a cross-sectional One Health surveillance study (2019–2024) in Quindío, Colombia, testing 42 pig fecal, 8 farm runoff, 4 tributary water samples, and 5 clinical serum samples from patients with hepatitis of undetermined etiology by reverse transcription quantitative PCR (RT-qPCR). Positive and selected clinical/environmental samples underwent Oxford Nanopore MinION sequencing targeting the open reading frame 2 and 3 (ORF2/ORF3) junction, k-mer fingerprinting (k = 25), consensus generation, phylogenetic analysis, and Sanger confirmation. HEV RNA was detected in 8/42 pig fecal samples (19.0%), 4/8 runoff samples (50.0%), 1/4 tributary samples (25.0%), and 4/5 serum samples (80.0%). K-mer analysis identified strong HEV signals in two clinical samples (44.5% and 39.5% of reads) and wastewater (97.2%). Phylogenetic analysis classified Colombian isolates within HEV-3 (bootstrap 83%), while Sanger sequencing confirmed HEV-specific motifs. Two sequences were deposited in GenBank (PZ262436, PZ262437), representing the first Colombian HEV-3 genomic records. These findings demonstrate HEV-3 circulation across porcine, environmental, and human compartments and highlight substantial genomic divergence, supporting locally calibrated molecular approaches and strengthened One Health genomic surveillance in Colombia and Latin America.
- 13 October 2026
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 11 (10) , 290
Open AccessHepatitis E Virus Genotype 3 in Quindío, Colombia: One Health Surveillance and First Genomic Characterization Reveal Cryptic Regional Divergence
Hepatitis E virus genotype 3 (HEV-3) is a zoonotic pathogen whose burden in Latin America remains underestimated. We conducted a cross-sectional One Health surveillance study (2019–2024) in Quindío, Colombia, testing 42 pig fecal, 8 farm runoff, 4 tributary water samples, and 5 clinical serum samples from patients with hepatitis of undetermined etiology by reverse transcription quantitative PCR (RT-qPCR). Positive and selected clinical/environmental samples underwent Oxford Nanopore MinION sequencing targeting the open reading frame 2 and 3 (ORF2/ORF3) junction, k-mer fingerprinting (k = 25), consensus generation, phylogenetic analysis, and Sanger confirmation. HEV RNA was detected in 8/42 pig fecal samples (19.0%), 4/8 runoff samples (50.0%), 1/4 tributary samples (25.0%), and 4/5 serum samples (80.0%). K-mer analysis identified strong HEV signals in two clinical samples (44.5% and 39.5% of reads) and wastewater (97.2%). Phylogenetic analysis classified Colombian isolates within HEV-3 (bootstrap 83%), while Sanger sequencing confirmed HEV-specific motifs. Two sequences were deposited in GenBank (PZ262436, PZ262437), representing the first Colombian HEV-3 genomic records. These findings demonstrate HEV-3 circulation across porcine, environmental, and human compartments and highlight substantial genomic divergence, supporting locally calibrated molecular approaches and strengthened One Health genomic surveillance in Colombia and Latin America.
- 26 August 2026
- Published by Springer Nature in Current Microbiology
- Vol. 83 (10) , 538
Inhibitory Effects of Oxysterlina 3, Satanin 1, and Curvicin Cecropins on the Growth and stx2 Gene Expression of Shiga Toxin-Producing Escherichia coli (STEC)
- 26 August 2026
- Published by Springer Nature in Current Microbiology
- Vol. 83 (10) , 538
Inhibitory Effects of Oxysterlina 3, Satanin 1, and Curvicin Cecropins on the Growth and stx2 Gene Expression of Shiga Toxin-Producing Escherichia coli (STEC)
- 18 November 2025
- Published by Asociacion Colombiana de Infectologia - ACIN in Infectio
- p. 228-238
Dengue and endothelium: a perspective on the pathophysiological implications of endothelial activation in dengue and its therapeutic possibilities
Introduction: Dengue is a widely spread viral febrile illness, with nearly half of the world’s population, approximately four billion people, living in areas at risk of dengue infection. It is often the leading cause of illness in these high-risk areas. Dengue is caused by four virus serotypes (Dengue 1, Dengue 2, Dengue 3, and Dengue 4). This virus is transmitted through the bites of infected female mosquitoes, primarily Aedes aegypti and Aedes albopictus. There is no specific medication to treat dengue, the and current management of the disease is symptomatic. Thus, an urgent search for specific therapeutic alternatives targeting the virus or the pathophysiological mechanisms responsible for severe forms of the disease is critical. The aim was to gather experimental evidence on the significance of endothelial activation in the pathophysiology of dengue, as available in the scientific literature. Materials and methods: A literatura search were conducted in English using the PubMed, Scopus, and ScienceDirect databases with the keywords dengue, endothelium, pathophysiology, and endothelial activation. Results: Experimental evidence has shown that endothelial dysfunction is central to the clinical manifestations of severe dengue. Discussion: The identification of pathophysiological mechanisms at the endotelial cell level has revealed numerous therapeutic targets for dengue, which need to be validated through clinical studies.
- 18 November 2025
- Published by Asociacion Colombiana de Infectologia - ACIN in Infectio
- p. 228-238
Dengue and endothelium: a perspective on the pathophysiological implications of endothelial activation in dengue and its therapeutic possibilities
Introduction: Dengue is a widely spread viral febrile illness, with nearly half of the world’s population, approximately four billion people, living in areas at risk of dengue infection. It is often the leading cause of illness in these high-risk areas. Dengue is caused by four virus serotypes (Dengue 1, Dengue 2, Dengue 3, and Dengue 4). This virus is transmitted through the bites of infected female mosquitoes, primarily Aedes aegypti and Aedes albopictus. There is no specific medication to treat dengue, the and current management of the disease is symptomatic. Thus, an urgent search for specific therapeutic alternatives targeting the virus or the pathophysiological mechanisms responsible for severe forms of the disease is critical. The aim was to gather experimental evidence on the significance of endothelial activation in the pathophysiology of dengue, as available in the scientific literature. Materials and methods: A literatura search were conducted in English using the PubMed, Scopus, and ScienceDirect databases with the keywords dengue, endothelium, pathophysiology, and endothelial activation. Results: Experimental evidence has shown that endothelial dysfunction is central to the clinical manifestations of severe dengue. Discussion: The identification of pathophysiological mechanisms at the endotelial cell level has revealed numerous therapeutic targets for dengue, which need to be validated through clinical studies.
- Open Access
- 12 July 2025
- Published by MDPI AG in Journal of Fungi
- Vol. 11 (7) , 519
Antimicrobial Peptides Act-6 and Act 8-20 Derived from Scarabaeidae Cecropins Exhibit Differential Antifungal Activity
The number of fungal infections is steadily increasing, with considerable morbidity and mortality. Additionally, antifungal resistance is a growing concern, highlighting the need to develop new treatment options. One alternative is the use of antimicrobial peptides (AMPs). The aim of this study was to assess the in vitro and in vivo antifungal activity of designed short AMPs, Act-6 and Act 8-20, derived from cecropin transcripts of beetles from the family Scarabaeidae, against eight reference strains of the pathogenic yeasts Candida and Cryptococcus. We also evaluated the effect of these modified AMPs on the biofilm, morphogenesis, and cell morphology of Candida albicans, as well as the in vivo activity via a murine model of disseminated candidiasis. The AMPs herein analyzed exhibit differential antifungal activity against the yeasts assessed, and inhibit biofilm, hyphae, and pseudohyphae formation with morphological alterations in C. albicans. Moreover, the fungal load in mice treated with these AMPs significantly decreased. Altogether, our results suggest that Act-6 and Act 8-20 are promising antifungal molecules to control mycoses.
- 12 July 2025
- Published by MDPI AG in Journal of Fungi
- Vol. 11 (7) , 519
Open AccessAntimicrobial Peptides Act-6 and Act 8-20 Derived from Scarabaeidae Cecropins Exhibit Differential Antifungal Activity
The number of fungal infections is steadily increasing, with considerable morbidity and mortality. Additionally, antifungal resistance is a growing concern, highlighting the need to develop new treatment options. One alternative is the use of antimicrobial peptides (AMPs). The aim of this study was to assess the in vitro and in vivo antifungal activity of designed short AMPs, Act-6 and Act 8-20, derived from cecropin transcripts of beetles from the family Scarabaeidae, against eight reference strains of the pathogenic yeasts Candida and Cryptococcus. We also evaluated the effect of these modified AMPs on the biofilm, morphogenesis, and cell morphology of Candida albicans, as well as the in vivo activity via a murine model of disseminated candidiasis. The AMPs herein analyzed exhibit differential antifungal activity against the yeasts assessed, and inhibit biofilm, hyphae, and pseudohyphae formation with morphological alterations in C. albicans. Moreover, the fungal load in mice treated with these AMPs significantly decreased. Altogether, our results suggest that Act-6 and Act 8-20 are promising antifungal molecules to control mycoses.
- Open Access
- 21 November 2024
- Published by Asociacion Colombiana de Infectologia - ACIN in Infectio
- p. 203-205
La biodiversidad es una barrera protectora de la salud global y una oportunidad para el desarrollo de nuestra biofarmacia para el mundo
Biodiversidad es una barrera protectora de la salud global y una oportunidad para el desarrollo de nuestra biofarmacia para el mundo. Infectio 2024; 24(4): 203-205 las poblaciones y dentro de ellas, de las especies autóctonas, silvestres y domesticadas se constituyan en barreras naturales para microorganismos y sus vectores, permanezcan confinados en sus entornos ecosistémicos naturales y evitar o minimizar, la ocurrencia de una nueva pandemia, tal como lo que vivimos recientemente con la COVID-19.
- 21 November 2024
- Published by Asociacion Colombiana de Infectologia - ACIN in Infectio
- p. 203-205
Open AccessLa biodiversidad es una barrera protectora de la salud global y una oportunidad para el desarrollo de nuestra biofarmacia para el mundo
Biodiversidad es una barrera protectora de la salud global y una oportunidad para el desarrollo de nuestra biofarmacia para el mundo. Infectio 2024; 24(4): 203-205 las poblaciones y dentro de ellas, de las especies autóctonas, silvestres y domesticadas se constituyan en barreras naturales para microorganismos y sus vectores, permanezcan confinados en sus entornos ecosistémicos naturales y evitar o minimizar, la ocurrencia de una nueva pandemia, tal como lo que vivimos recientemente con la COVID-19.
- Open Access
- 15 July 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (7) , 851
Assessment of Antimicrobial and Cytotoxic Activities of Liposomes Loaded with Curcumin and Lippia origanoides Essential Oil
(1) Introduction: Curcumin and Lippia origanoides essential oils have a broad spectrum of biological activities; however, their physicochemical instability, low solubility, and high volatility limit their therapeutic use. Encapsulation in liposomes has been reported as a feasible approach to increase the physicochemical stability of active substances, protect them from interactions with the environment, modulate their release, reduce their volatility, improve their bioactivity, and reduce their toxicity. To date, there are no reports on the co-encapsulation of curcumin and Lippia origanoides essential oils in liposomes. Therefore, the objective of this work is to prepare and physiochemical characterize liposomes loaded with the mixture of these compounds and to evaluate different in vitro biological activities. (2) Methods: Liposomes were produced using the thin-layer method and physiochemical characteristics were calculated. The antimicrobial and cytotoxic activities of both encapsulated and non-encapsulated compounds were evaluated. (3) Results: Empty and loaded nanometric-sized liposomes were obtained that are monodisperse and have a negative zeta potential. They inhibited the growth of Staphylococcus aureus and did not exhibit cytotoxic activity against mammalian cells. (4) Conclusions: Encapsulation in liposomes was demonstrated to be a promising strategy for natural compounds possessing antimicrobial activity.
- 15 July 2024
- Published by MDPI AG in Biomolecules
- Vol. 14 (7) , 851
Open AccessAssessment of Antimicrobial and Cytotoxic Activities of Liposomes Loaded with Curcumin and Lippia origanoides Essential Oil
(1) Introduction: Curcumin and Lippia origanoides essential oils have a broad spectrum of biological activities; however, their physicochemical instability, low solubility, and high volatility limit their therapeutic use. Encapsulation in liposomes has been reported as a feasible approach to increase the physicochemical stability of active substances, protect them from interactions with the environment, modulate their release, reduce their volatility, improve their bioactivity, and reduce their toxicity. To date, there are no reports on the co-encapsulation of curcumin and Lippia origanoides essential oils in liposomes. Therefore, the objective of this work is to prepare and physiochemical characterize liposomes loaded with the mixture of these compounds and to evaluate different in vitro biological activities. (2) Methods: Liposomes were produced using the thin-layer method and physiochemical characteristics were calculated. The antimicrobial and cytotoxic activities of both encapsulated and non-encapsulated compounds were evaluated. (3) Results: Empty and loaded nanometric-sized liposomes were obtained that are monodisperse and have a negative zeta potential. They inhibited the growth of Staphylococcus aureus and did not exhibit cytotoxic activity against mammalian cells. (4) Conclusions: Encapsulation in liposomes was demonstrated to be a promising strategy for natural compounds possessing antimicrobial activity.
- Open Access
- 1 January 2024
- Published by Universidad Nacional de Colombia in Revista de Salud Pública
- Vol. 26 (1) , 1-6
Articulación de la medicina alternativa y complementaria en el Sistema de Seguridad Social en el Quindío - Colombia durante el 2020
Objetivo Describir la oferta de los servicios de medicina alternativa y complementaria (mac) en el departamento del Quindío y su articulación en las instituciones del Sistema General de Seguridad Social en Salud (SGSSS). Metodología Estudio descriptivo sobre la oferta de mac en el Registro Especial de Prestadores de Servicios de Salud (reps), las características del ejercicio médico y el acceso, la articulación y la integración en la oferta pública y privada. Resultados Se identificaron veintidós prestadores registrados en el reps que ejercen en la consulta médica privada, número que no ha aumentado desde el año 2010. Se evidenció prestación de mac en seis planes complementarios: dos aseguradoras, dos administradoras de planes de beneficios y dos que ofrecen un carnet de descuentos. Se identificaron tres experiencias de oferta de mac en instituciones públicas del primer nivel de atención, dos de las cuales subsisten, una de ellas con cobertura a personas del régimen subsidiado. Conclusiones Este trabajo evidencia las barreras de acceso a los servicios de mac, las limitaciones en la oferta en las instituciones públicas del SGSSS y la articulación en algunos planes complementarios en la oferta privada. La oferta de mac en condiciones de equidad es a la fecha un reto y una oportunidad para el SGSSS.
- 1 January 2024
- Published by Universidad Nacional de Colombia in Revista de Salud Pública
- Vol. 26 (1) , 1-6
Open AccessArticulación de la medicina alternativa y complementaria en el Sistema de Seguridad Social en el Quindío - Colombia durante el 2020
Objetivo Describir la oferta de los servicios de medicina alternativa y complementaria (mac) en el departamento del Quindío y su articulación en las instituciones del Sistema General de Seguridad Social en Salud (SGSSS). Metodología Estudio descriptivo sobre la oferta de mac en el Registro Especial de Prestadores de Servicios de Salud (reps), las características del ejercicio médico y el acceso, la articulación y la integración en la oferta pública y privada. Resultados Se identificaron veintidós prestadores registrados en el reps que ejercen en la consulta médica privada, número que no ha aumentado desde el año 2010. Se evidenció prestación de mac en seis planes complementarios: dos aseguradoras, dos administradoras de planes de beneficios y dos que ofrecen un carnet de descuentos. Se identificaron tres experiencias de oferta de mac en instituciones públicas del primer nivel de atención, dos de las cuales subsisten, una de ellas con cobertura a personas del régimen subsidiado. Conclusiones Este trabajo evidencia las barreras de acceso a los servicios de mac, las limitaciones en la oferta en las instituciones públicas del SGSSS y la articulación en algunos planes complementarios en la oferta privada. La oferta de mac en condiciones de equidad es a la fecha un reto y una oportunidad para el SGSSS.
- Open Access
Antiviral Activity of an Indole-Type Compound Derived from Natural Products, Identified by Virtual Screening by Interaction on Dengue Virus NS5 Protein
Dengue is an acute febrile illness caused by the Dengue virus (DENV), with a high number of cases worldwide. There is no available treatment that directly affects the virus or the viral cycle. The objective of this study was to identify a compound derived from natural products that interacts with the NS5 protein of the dengue virus through virtual screening and evaluate its in vitro antiviral effect on DENV-2. Molecular docking was performed on NS5 using AutoDock Vina software, and compounds with physicochemical and pharmacological properties of interest were selected. The preliminary antiviral effect was evaluated by the expression of the NS1 protein. The effect on viral genome replication and/or translation was determined by NS5 production using DENV-2 Huh-7 replicon through ELISA and viral RNA quantification using RT-qPCR. The in silico strategy proved effective in finding a compound (M78) with an indole-like structure and with an effect on the replication cycle of DENV-2. Treatment at 50 µM reduced the expression of the NS5 protein by 70% and decreased viral RNA by 1.7 times. M78 is involved in the replication and/or translation of the viral genome.
Open AccessAntiviral Activity of an Indole-Type Compound Derived from Natural Products, Identified by Virtual Screening by Interaction on Dengue Virus NS5 Protein
Dengue is an acute febrile illness caused by the Dengue virus (DENV), with a high number of cases worldwide. There is no available treatment that directly affects the virus or the viral cycle. The objective of this study was to identify a compound derived from natural products that interacts with the NS5 protein of the dengue virus through virtual screening and evaluate its in vitro antiviral effect on DENV-2. Molecular docking was performed on NS5 using AutoDock Vina software, and compounds with physicochemical and pharmacological properties of interest were selected. The preliminary antiviral effect was evaluated by the expression of the NS1 protein. The effect on viral genome replication and/or translation was determined by NS5 production using DENV-2 Huh-7 replicon through ELISA and viral RNA quantification using RT-qPCR. The in silico strategy proved effective in finding a compound (M78) with an indole-like structure and with an effect on the replication cycle of DENV-2. Treatment at 50 µM reduced the expression of the NS5 protein by 70% and decreased viral RNA by 1.7 times. M78 is involved in the replication and/or translation of the viral genome.
- Open Access
- 16 August 2022
- Published by Editorial Pontificia Universidad Javeriana in Universitas Scientiarum
- Vol. 27 (2) , 187-202
Characterization of six Shiga toxin-producing Escherichia coli (STEC) strains carrying Stx2-phages from Colombia
Shiga toxin producing Escherichia coli (STEC) is a bacterial pathogen that causes diarrhea and severe human diseases like HUS; its main virulence factor are the Shiga toxins (Stx1 and Stx2). Some Stx2 subtypes have been identified and associated with the risk of developing severe illness. Stx toxins are encoded in temperate bacteriophages which control their expression through the lytic cycle that is regulated by the late genes and Q anti-terminator protein. The aim of this work was to characterize six STEC strains carrying Stx2-phages to provide preliminary information and understanding about Stx2 strains from Colombia regarding the Stx production, lytic cycle induction and subtyping of Stx2. Two highlighted strains with higher levels of Stx production and lytic cycle’s induction were observed. All the evaluated strains carried either the Stx2a, Stx2c, or Stx2d subtypes. In addition, most of the strains carried the qO111 allele, and only one strain showed differences in the ninG region. Differences in the evaluated characteristics of the strains were observed, which could indicate the variability of these six STEC strains carrying Stx2-phages.
- 16 August 2022
- Published by Editorial Pontificia Universidad Javeriana in Universitas Scientiarum
- Vol. 27 (2) , 187-202
Open AccessCharacterization of six Shiga toxin-producing Escherichia coli (STEC) strains carrying Stx2-phages from Colombia
Shiga toxin producing Escherichia coli (STEC) is a bacterial pathogen that causes diarrhea and severe human diseases like HUS; its main virulence factor are the Shiga toxins (Stx1 and Stx2). Some Stx2 subtypes have been identified and associated with the risk of developing severe illness. Stx toxins are encoded in temperate bacteriophages which control their expression through the lytic cycle that is regulated by the late genes and Q anti-terminator protein. The aim of this work was to characterize six STEC strains carrying Stx2-phages to provide preliminary information and understanding about Stx2 strains from Colombia regarding the Stx production, lytic cycle induction and subtyping of Stx2. Two highlighted strains with higher levels of Stx production and lytic cycle’s induction were observed. All the evaluated strains carried either the Stx2a, Stx2c, or Stx2d subtypes. In addition, most of the strains carried the qO111 allele, and only one strain showed differences in the ninG region. Differences in the evaluated characteristics of the strains were observed, which could indicate the variability of these six STEC strains carrying Stx2-phages.
- Open Access
PD1 CD44 antiviral peptide as an inhibitor of the protein-protein interaction in dengue virus invasion